About Sanger Genomics Private Limited
Data last updated:
Sanger Genomics Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the wellness and healthcare centers segment of the travel and hospitality sector. It was incorporated on 13 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2015PTC265522. Its GSTIN is 27AAVCS9097D1ZI (Maharashtra).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Milind Vipul Doshi and Manisha Vipul Doshi.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Floor – 9 Plot – 207 Embassy Centre Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2023, the company reported a revenue of ₹26.19 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.12 Lakh (net margin -11.9%) and EBITDA of -₹2.78 Lakh (EBITDA margin -10.6%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 20% over five years.
The company is associated with 1 brand: Nutritional Genomix.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nutritionalgenomix.com.
Company details
Contact details
Sanger Genomics Private Limited's registered office is in Mumbai, Maharashtra. Its website is nutritionalgenomix.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFloor – 9 Plot – 207 Embassy Centre Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryTravel and Hospitality, Wellness & Healthcare Centers
To see the full contact details of Sanger Genomics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sanger Genomics operates one associated brand: Nutritional Genomix. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides personalized genetic testing services for health and fitness optimization. | nutritionalgenomix.com |
Business activity
The main business activity of Sanger Genomics is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Sanger Genomics Private Limited, buy the company report.
Financials of Sanger Genomics Private Limited
FY 2023 filings availableSanger Genomics Private Limited reported revenue of ₹26.19 Lakh (up 346% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 346% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 20%. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.12 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.6% | ||||
| Net Profit Margin | -11.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanger Genomics Private Limited, buy the company report.
Board of directors of Sanger Genomics Private Limited
Sanger Genomics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Milind Vipul Doshi Also directs: Whiton Chem Private Limited, Rapport Holding and Commercial Private Limited, Sanchana Leasing and Investments Ltd. and 2 more | Director | 13 Jun 2015 | 11 Years 4 Months | Current |
| Manisha Vipul Doshi | Director | 13 Jun 2015 | 11 Years 4 Months | Current |
Auditor
Sanger Genomics Private Limited is audited by N Z & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N Z & ASSOCIATES | FY 2019 | 140464W |
Shareholding
The shareholding of Sanger Genomics Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sanger Genomics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sanger Genomics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanger Genomics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sanger Genomics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAVCS9097D1ZI | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sanger Genomics Private Limited, buy the company report.
Recent activity
Sanger Genomics Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Manisha Vipul Doshi was appointed as Director on 13 Jun 2015.
Frequently asked questions
Sanger Genomics is an active private limited company based in Mumbai, Maharashtra, India. The company works in wellness and healthcare centers, within the travel and hospitality industry. It was incorporated on 13 June 2015 (11+ years old) and is registered under CIN U74120MH2015PTC265522.
Sanger Genomics has 2 current directors:
- Milind Vipul Doshi - Director
- Manisha Vipul Doshi - Director
The latest financial statements of Sanger Genomics on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sanger Genomics is 27AAVCS9097D1ZI, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sanger Genomics is U74120MH2015PTC265522. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanger Genomics was incorporated on 13 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Manisha Vipul Doshi was appointed as Director on 13 Jun 2015. Milind Vipul Doshi was appointed as Director on 13 Jun 2015.
Sanger Genomics can be reached through the website nutritionalgenomix.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Sanger Genomics is at Floor – 9 Plot – 207 Embassy Centre Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
Sanger Genomics operates in the travel and hospitality industry, in the wellness and healthcare centers segment.